Inclusion of children in clinical trials of treatments for COVID-19


What Viewpoint Says:

This Viewpoint discusses the exclusion of children from coronavirus disease 2019 (COVID-19) clinical trials and why that could harm treatment options for children.


Authors:

Florence T. Bourgeois, M.D., M.P.H., of Boston Children’s Hospital and Harvard Medical School is Boston, is the corresponding author.


To access the embargoed study:

Visit our For The Media website at this link

https:/

/

media.

jamanetwork.

com/

(doi:10.1001/jamapediatrics.2020.1888)


Editor’s Note:

The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

###


Media advisory:

The full article is linked to this news release.


Embed this link to provide your readers free access to the full-text article

This link will be live at the embargo time

https:/

/

jamanetwork.

com/

journals/

jamapediatrics/

fullarticle/

10.

1001/

jamapediatrics.

2020.

1888?guestAccessKey=

57a0058e-496b-4d2a-8b8d-aa6a54a8feb7&utm_source=

For_The_Media&utm_medium=

referral&utm_campaign=

ftm_links&utm_content=

tfl&utm_term=

050720

This part of information is sourced from https://www.eurekalert.org/pub_releases/2020-05/jn-ioc050620.php

withyou android app